THE 9D BIOTECH TEAM
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
DR. BRUNO RUGGIERO, PH.D
president
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
MS. VERONICA SATCHKOVA
chief financial officer
CHIEF EXECUTIVE OFFICER
CHIEF PHYSICIAN EXECUTIVE
MR. DAVID RISTENPART
CHIEF PHYSICIAN EXECUTIVE
CHIEF PHYSICIAN EXECUTIVE
CHIEF PHYSICIAN EXECUTIVE
DR. WILLIAM BITHONEY, MD, FAAP
SCIENTIFIC BOARD MEMBER
CHIEF PHYSICIAN EXECUTIVE
SCIENTIFIC BOARD MEMBER
DR. DOUGLAS WATT, PH.D.
SCIENTIFIC BOARD MEMBER
CHIEF PHYSICIAN EXECUTIVE
SCIENTIFIC BOARD MEMBER
DR. EDDO RUGINI, PH.D.
PLANTING THE SEEDS OF HUMAN HEALTH
MISSION
Our mission is to commercialise advanced, scientifically acclaimed discoveries in the field of biotechnology for the improvement of both human and environmental health.
HISTORY
9th Dimension Biotech, Inc. was founded in the U.S. in 2013 and is led by a team of world-renown scientists, physicians, and experienced entrepreneurs.
IP PORTFOLIO
9D Biotech has developed an exclusive IP Portfolio of cutting-edge biotechnologies at various stages of development and commercialisation with enormous potential to address key global issues in a sustainable and science-driven way.
RESEARCH & DEVELOPMENT
We have built a unique network of cooperations and strategic alliances with some of the world's top scientific and medical minds and laboratories, allowing us to select and develop the highest quality technologies on international scale.
PRODUCTION
9D Biotech's first product FORZA is the world's first and only Osmotin Protein rich Anti-Aging Super-Food. Our proprietary technology allows us to mass-produce the Osmotin protein, making this extremely beneficial but prohibitively expensive plant protein finally accessible to consumers worldwide.
Dr. William Bithoney, MD FAAP joins 9d biotech
We are proud and honoured to announce that Dr. William Bithoney, MD FAAP has joined the 9D Biotech team as Chief Physician Executive and Chief Science Officer.
Dr. Bithoney brings his invaluable expertise as a leading physician and highly experienced healthcare professional with more than 35 years of experience in the healthcare sector, having served as a physician executive in diverse academic and hospital systems. He is skilled in developing managed care strategies, academic strategies, a self-sustaining cycle of continuous performance and quality improvement, utilization review, utilization management, and research directions.
Dr. Bithoney's participation in 9D Biotech signals a new and important stage of the company's growth and confirms Forza's great potential to improve human health-span, life-span, and well being.
9D Biotech & Forza Fans at the Office of the Italian Prime Minister
February 28th, 2019
Our CEO, Dr. Bruno Ruggiero, was honored to be invited and to participate at the multilateral convention aimed at shining a light on rare pathologies, providing additional support to research and better assistance to patients by offering a platform for doctors, patients, non-profit organisations, researchers, and political representatives to exchange ideas and discuss innovative approaches together at the highest institutional levels in Italy.
"I wish to express my sincere gratitude for your participation at the convention I organized in occasion of the 12th annual world rare disease day."
dr.ssa Antonella Picariello
coll. sen. Marco Croatti
A special invitation was also extended by the organizers to a diabetes-associated peripheral neuropathy patient from Monte Carlo (see picture above), who wished to personally testify about his experience with our Forza product before the Ministry, as part of Dr. Ruggiero's presentation of the results of his latest scientific work.
XII Giornata Mondiale Malattie Rare, "Le malattie rare e la disabilità" Programme and Attendees
Non-Profit Organisations, Patients, and Leading Medical Institutions joining forces for real change.
Non-Profit Organisations, Patients, and Leading Medical Institutions joining forces for real change.
Click below to view the official document issued by the Office of the Prime Minister announcing the Programme and Attendees of the Convention.
Non-Profit Organisations, Patients, and Leading Medical Institutions joining forces for real change.
Non-Profit Organisations, Patients, and Leading Medical Institutions joining forces for real change.
Non-Profit Organisations, Patients, and Leading Medical Institutions joining forces for real change.
Learn more about the event from Mitocon - Italy's main Mitochondrial Diseases association.
International Conference of Biotechnology & Environment
Seeds and Chips Global Food Innovation Summit, Milan, Italy
Seeds and Chips Global Food Innovation Summit, Milan, Italy
9D Biotech is proud to announce that our Osmotin over-expressing Olive Trees and Osmotin over expressing Kiwi Vines were selected as the best biotechnology product for the environment and agriculture by the Independent Scientific panel of The 2nd International Conference of Biotechnology and Environment (ICBE 2018) held on the 28-30 March, 2018 in Alexandria, Egypt. Our partner team of Tuscia University, Italy, lead by Professor Eddo Rugini, were invited to presented the work as opening speakers of the conference.
Seeds and Chips Global Food Innovation Summit, Milan, Italy
Seeds and Chips Global Food Innovation Summit, Milan, Italy
Seeds and Chips Global Food Innovation Summit, Milan, Italy
9D Biotech had the pleasure to present our Osmotin age-reversing product line at the 2017 Seeds and Chips Global Food Innovation Summit held this May 8th-11th in Milan, Italy, with the 44th President of the United States of America Barack H. Obama being the guest of honor and keynote speaker at the Symposium.